These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3260318)

  • 1. In vitro binding properties and autoradiographic imaging of 3-iodobenzamide ([125I]-IBZM): a potential imaging ligand for D-2 dopamine receptors in SPECT.
    Brücke T; Tsai YF; McLellan C; Singhanyom W; Kung HF; Cohen RM; Chiueh CC
    Life Sci; 1988; 42(21):2097-104. PubMed ID: 3260318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of in vivo binding of 125I-labeled 3-iodobenzamide (IBZM) to dopamine receptors by D2 antagonist and agonist.
    Singhaniyom W; Tsai YF; Brücke T; McLellan CA; Cohen RM; Kung HF; Chiueh CC
    Brain Res; 1988 Jun; 453(1-2):393-6. PubMed ID: 2969766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo D2-dopamine receptor binding with [123I]S(-) iodobenzamide ([123I]IBZM) in rat and human brain.
    Verhoeff NP; Bobeldijk M; Feenstra MG; Boer GJ; Maas MA; Erdtsieck-Ernste E; de Bruin K; van Royen EA
    Int J Rad Appl Instrum B; 1991; 18(8):837-46. PubMed ID: 1839302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine D-2 receptor imaging radiopharmaceuticals: synthesis, radiolabeling, and in vitro binding of (R)-(+)- and (S)-(-)-3-iodo-2-hydroxy-6-methoxy-N- [(1-ethyl-2-pyrrolidinyl)methyl]benzamide.
    Kung HF; Kasliwal R; Pan SG; Kung MP; Mach RH; Guo YZ
    J Med Chem; 1988 May; 31(5):1039-43. PubMed ID: 2966245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo evaluation of [123I]IBZM: a potential CNS D-2 dopamine receptor imaging agent.
    Kung HF; Pan S; Kung MP; Billings J; Kasliwal R; Reilley J; Alavi A
    J Nucl Med; 1989 Jan; 30(1):88-92. PubMed ID: 2783457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of membrane-bound and soluble D2 receptors in canine caudate using [125I]IBZM.
    Schonwetter BS; Luedtke RR; Kung MP; Billings J; Kung HF; Molinoff PB
    J Pharmacol Exp Ther; 1989 Jul; 250(1):110-6. PubMed ID: 2526213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and biodistribution of [125I]IBZM: a potential CNS D-2 dopamine receptor imaging agent.
    Kung HF; Guo YZ; Billings J; Xu X; Mach RH; Blau M; Ackerhalt RE
    Int J Rad Appl Instrum B; 1988; 15(2):195-201. PubMed ID: 2966782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The discovery of epidepride and its analogs as high-affinity radioligands for imaging extrastriatal dopamine D(2) receptors in human brain.
    de Paulis T
    Curr Pharm Des; 2003; 9(8):673-96. PubMed ID: 12570798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High affinity dopamine D2 receptor radioligands. 2. [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptors.
    Kessler RM; Ansari MS; Schmidt DE; de Paulis T; Clanton JA; Innis R; al-Tikriti M; Manning RG; Gillespie D
    Life Sci; 1991; 49(8):617-28. PubMed ID: 1830917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NCQ 298, a new selective iodinated salicylamide ligand for the labelling of dopamine D2 receptors.
    Hall H; Högberg T; Halldin C; Köhler C; Ström P; Ross SB; Larsson SA; Farde L
    Psychopharmacology (Berl); 1991; 103(1):6-18. PubMed ID: 1672460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates.
    Innis RB; Malison RT; al-Tikriti M; Hoffer PB; Sybirska EH; Seibyl JP; Zoghbi SS; Baldwin RM; Laruelle M; Smith EO
    Synapse; 1992 Mar; 10(3):177-84. PubMed ID: 1532675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of in vivo D-2 dopamine receptor binding of IBZM and NMSP in rat brain.
    Kung HF; Billings JJ; Guo YZ; Mach RH
    Int J Rad Appl Instrum B; 1988; 15(2):203-8. PubMed ID: 2966783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and characterization of iodobenzamide analogues: potential D-2 dopamine receptor imaging agents.
    Murphy RA; Kung HF; Kung MP; Billings J
    J Med Chem; 1990 Jan; 33(1):171-8. PubMed ID: 2136916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-[125I]iodo- 2-methoxybenzamide hydrochloride, a new selective radioligand for dopamine D-2 receptors.
    de Paulis T; Janowsky A; Kessler RM; Clanton JA; Smith HE
    J Med Chem; 1988 Oct; 31(10):2027-33. PubMed ID: 3172140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, in vitro binding profile and biodistribution of a 125I-labeled N-benzyl pyrrolidinyl benzamide derivative: a potential radioligand for mapping dopamine D2 receptors.
    Saji H; Tanahashi K; Kinoshita T; Iida Y; Magata Y; Yokoyama A
    Nucl Med Biol; 1996 Feb; 23(2):121-7. PubMed ID: 8868283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain.
    Köhler C; Hall H; Ogren SO; Gawell L
    Biochem Pharmacol; 1985 Jul; 34(13):2251-9. PubMed ID: 4015674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium-dependent isomerization of dopamine D-2 receptors characterized using [125I]epidepride, a high-affinity substituted benzamide ligand.
    Neve KA; Henningsen RA; Kinzie JM; De Paulis T; Schmidt DE; Kessler RM; Janowsky A
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1108-16. PubMed ID: 2138666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and binding properties of the fluorinated substituted benzamide [3H]NCQ 115, a new selective dopamine D2 receptor ligand.
    Hall H; Högberg T; Halldin C; Bengtsson S; Wedel I
    Eur J Pharmacol; 1991 Aug; 201(1):1-10. PubMed ID: 1686586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vivo characteristics of IBZM in rat brains: an agent for quantitative SPECT imaging of dopamine D2 receptors. Preparation of 125I-IBZM and its biodistribution and kinetic properties].
    Matsumura K; Toyama H; Nakashima H; Ichise M; Kurami M; Nakagawa T; Maeda H; Takeuchi A; Koga S
    Kaku Igaku; 1994 May; 31(5):513-9. PubMed ID: 8028224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The D1 dopamine receptor in the rat brain: quantitative autoradiographic localization using an iodinated ligand.
    Dawson TM; Barone P; Sidhu A; Wamsley JK; Chase TN
    Neuroscience; 1988 Jul; 26(1):83-100. PubMed ID: 2971144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.